# FDA Inspection 1303254 - Jeff Livingston, MD - February 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/jeff-livingston-md/87322f3f-be8a-4789-b736-22ffa5f3c2ff
Source feed: FDA_Inspections

> FDA Inspection 1303254 for Jeff Livingston, MD on February 17, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303254
- Company Name: Jeff Livingston, MD
- Inspection Date: 2026-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1303254 - 2026-02-17](https://www.keypedia.com/records/fda_inspections/jeff-livingston-md/6441608c-744c-430e-9008-39b7c3f9a9f9)
- [FDA Inspection 1134446 - 2020-12-14](https://www.keypedia.com/records/fda_inspections/jeff-livingston-md/8856b044-eb85-4712-af1e-e1592499cdbe)

Company: https://www.keypedia.com/companies/jeff-livingston-md/2e7e3c3f-3901-444c-ab78-032d4439ee20